Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Clinical trial NCT05797831 · RECRUITING
Trial details
- NCT number
- NCT05797831
- Sponsor
- Kartos Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-17
- Primary completion
- 2025-08-01
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.